KLK3 and prostate carcinoma: A baseline or early PSA test result in younger men has been demonstrated in many studies to correlate with the likelihood of prostate cancer diagnosis (6–10) during their lifetime, and even likelihood of developing metastases (8) and prostate cancer-specific death (8, 10–12).